Skip to main content

Table 1 Identification of high risk human papilloma viruses in prostate cancer. Case control studies with normal and benign prostate tissues as controls

From: Evidence for a causal role by human papillomaviruses in prostate cancer – a systematic review

Study Country Prostate cancer Prostate control Main HPV types P value   
McNichol 1991 [12] Canada 14/27 52% 1/5 20% normal
34/56 61% benign
16,18 0.396 ns
0.690 ns
  
Anwar 1992 [14] Japan 28/68 41% 0/10 0% 16,18,33 0.221 ns   
Ibrahim 1992 [15] US 6/40 15% 2/29 7% 16 0.344 ns   
Rotola 1992 [16] Italy 6/8 75% 14/17 82% 16 0.0.815 ns   
Dodd 1993 [17] Canada 3/7 43% 5/10 50% 16 0.0.841 ns   
Tu 1994 [18] US 1/43 0/1 16    
Moyret-Lalle 1995 [19] France 9/17 53% 7/22 32% 16 0.682 ns   
Wideroff 1996 [20] US 7/56 13% 4/42 10% 16,18,31,33,45 0.654 ns   
Terris 1997 [21] US 10/53 19% 5/37 14% normal
7/21 33% benign
16
16
0.571 ns   
Serth 1999 [22] Germany 10/47 21% 1/37 3% 16 0.027 s   
Carozzi 2004 [23] Italy 6/24 25% 3/25 12% 16,18,31 0.333 ns   
Leiros 2005 [24] Argentina 15/41 37% 0/30 0% 16 0.011 s   
Silvestre 2009 [25] Brazil 2/65 3% 0/6 0% 16    
Martinez-Fierro 2010 [26] Mexico 11/55 20% 4/75 5% 33,45,52,58,66 0.020 s   
Aghakhani 2011 [27] Iran 10/104 10% 5/104 5% 16,18 0.213 ns   
Chen 2011 [12] Australia 7/51 14% 3/11 27% 18 0.367 ns   
Tachezy 2012 [28] Czech 1/51 2% 2/95 2%     
Whitaker 2013 [29] Australia 29/50 58% 8/50 16% 18 0.003 s   
Ghasemian 2013 [30] Iran 5/29 17% 8/167 5%   0.026 s   
Mokhtari 2013 [31] Iran 3/30 10% 1/90 1%     
Michopoulou 2014 [32] Greece 8/50 16% 1/30 3% 16, 18, 31 0.127 ns   
Singh 2015 [33] India 36/95 38% 4/55 7% 16,18 0.001 s   
Huang 2016 [34] China 30/75 40% 9/73 12%   0.001 s   
Davila Rodriquez 2016 [35] Mexico 12/62 19% 1/25 4% 18,51,52 0.104 ns   
Atashafrooz 2016 [36] Iran 16/100 16% 2/100 2% 16,18,31,33,54 0.002 s   
Medel Flores 2018 [37] Mexico 37/189 20% 16/167 10% 16,18,31,33,52,58 0.014 s   
  1. p = 0.05. s = significant. ns = not significant